News

CliniOps Announces Strategic Partnership With Indegene to Accelerate Clinical Trials

Offers an end-to-end platform for patient recruitment, data management, Biostatistics and regulatory submission FREMONT, CALIFORNIA / ACCESSWIRE / January 9,…

12 months ago

Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco

LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company…

12 months ago

Nanomerics Reports Complete Dosing of the Last Volunteer in the OC134 SUNLIGHT Trial

LONDON, GB / ACCESSWIRE / January 9, 2025 / Nanomerics Ltd., a private speciality pharmaceutical company today announced that it…

12 months ago

AI/ML Innovations Inc. Welcomes Industry Veterans to Board of Directors

Mark Orsmond, a highly respected business professional in Canadian Healthcare, Appointed Executive ChairMichael Nemirow Joins as Director, Bringing Decades of…

12 months ago

BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco

Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciencesMeet BioLizard’s…

12 months ago

Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference

Accelerating IMPT-314 in large B-cell lymphoma; remain on track to initiate pivotal trial in the 3rd line+ setting in 2025…

12 months ago

Inmagene Reports Positive Topline Results of IMG-007, a Nondepleting Anti-OX40 Monoclonal Antibody with an Extended Half-Life, for the Treatment of Atopic Dermatitis

A 4-week treatment with IMG-007 resulted in a mean reduction in eczema area and severity index (EASI) of 77% and…

12 months ago

Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology

Cannabix Technologies Inc. Cannabix Breath Collection Unit (“BCU”) with Breath Cartridge technology VANCOUVER, British Columbia, Jan. 09, 2025 (GLOBE NEWSWIRE)…

12 months ago

FYR Appoints Chris Howlett to its Board of Directors

Appointment adds business, market and partner development expertise to FYR board Addition highlights FYR’s evolution into partner of choice for…

12 months ago

Alkeus Pharmaceuticals Announces New Positive Interim TEASE-3 Study Results Showing Gildeuretinol Prevented Disease Progression in Early-Stage Stargardt Patients

Two additional TEASE-3 participants who recently completed 24 months of therapy showed no disease progression, consistent with prior results. A…

12 months ago